As of 2025-07-14, the Relative Valuation of Esperion Therapeutics Inc (ESPR) is (13.90) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.19 USD, the upside of Esperion Therapeutics Inc based on Relative Valuation is -1267.7%.
The range of the Relative Valuation is (11.53) - (15.97) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.6x - 25.0x | 19.0x |
| Forward P/E multiples | 14.9x - 20.7x | 16.9x |
| Fair Price | (11.53) - (15.97) | (13.90) |
| Upside | -1069.3% - -1442.1% | -1267.7% |
| Date | P/E |
| 2025-07-11 | -1.54 |
| 2025-07-10 | -1.60 |
| 2025-07-09 | -1.59 |
| 2025-07-08 | -1.51 |
| 2025-07-07 | -1.44 |
| 2025-07-03 | -1.51 |
| 2025-07-02 | -1.49 |
| 2025-07-01 | -1.29 |
| 2025-06-30 | -1.27 |
| 2025-06-27 | -1.29 |
| 2025-06-26 | -1.32 |
| 2025-06-25 | -1.31 |
| 2025-06-24 | -1.38 |
| 2025-06-23 | -1.35 |
| 2025-06-20 | -1.38 |
| 2025-06-18 | -1.42 |
| 2025-06-17 | -1.41 |
| 2025-06-16 | -1.51 |
| 2025-06-13 | -1.51 |
| 2025-06-12 | -1.55 |
| 2025-06-11 | -1.57 |
| 2025-06-10 | -1.58 |
| 2025-06-09 | -1.55 |
| 2025-06-06 | -1.58 |
| 2025-06-05 | -1.50 |
| 2025-06-04 | -1.45 |
| 2025-06-03 | -1.36 |
| 2025-06-02 | -1.19 |
| 2025-05-30 | -1.10 |
| 2025-05-29 | -1.13 |
| 2025-05-28 | -1.08 |
| 2025-05-27 | -1.06 |
| 2025-05-23 | -1.02 |
| 2025-05-22 | -1.04 |
| 2025-05-21 | -1.10 |
| 2025-05-20 | -1.18 |
| 2025-05-19 | -1.12 |
| 2025-05-16 | -1.04 |
| 2025-05-15 | -1.01 |
| 2025-05-14 | -0.94 |
| 2025-05-13 | -1.01 |
| 2025-05-12 | -1.03 |
| 2025-05-09 | -1.03 |
| 2025-05-08 | -1.15 |
| 2025-05-07 | -1.13 |
| 2025-05-06 | -1.26 |
| 2025-05-05 | -1.36 |
| 2025-05-02 | -1.41 |
| 2025-05-01 | -1.27 |
| 2025-04-30 | -1.29 |